Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.86 USD | -2.79% |
|
+6.49% | -6.45% |
06-14 | Raymond James Adjusts Price Target on Xencor to $40 From $58, Maintains Strong Buy Rating | MT |
06-14 | BMO Capital Adjusts Xencor's Price Target to $32 From $34, Keeps Outperform Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.45% | 1.26B | |
+20.03% | 126B | |
+23.61% | 118B | |
+23.26% | 27.87B | |
-18.07% | 20.95B | |
-15.13% | 16.92B | |
-14.81% | 16.18B | |
+9.78% | 14.84B | |
-46.10% | 14.79B | |
+52.34% | 14.08B |
- Stock Market
- Equities
- XNCR Stock
- News Xencor, Inc.
- Transcript : Xencor, Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-11-2023 03